home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Compliance with the New ICH GCP Revision 2 Addendum

 
  February 25, 2019  
     
 
Netzealous LLC DBA - Compliance4All, Online
2019-04-01


Overview:
This will enable you to meet the new international GCP standard to ensure regulatory compliance and the acceptance of clinical trial data by the regulatory authorities internationally.

Why should you Attend:
With the new ICH GCP E6 Revision 2 Addendum now finalised the changes should have been implemented for organisations running clinical trials.

Areas Covered in the Session:
Review the new requirements for Sponsor and Investigator Oversight
Understand requirements for CROs, quality systems
Explore risk based approaches for clinical trials
Consider changes for the TMF
Best practice for Clinical QMS

Who Will Benefit:
Global Clinical Safety and Pharmacovigilance Officers
Compliance Staff
Clinical Quality Auditors
Quality Assurance Personnel
Document management

Event Fee: One Dial-in One Attendee Price: US $150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: compliance4all14@gmail.com
 
 
Organized by: Event Manager
Invited Speakers:
Speaker Profile:
Dr. Laura Brown , PhD, MBA, Diploma Clinical Sciences, is an independent QA and training consultant in the pharmaceutical industry. She is a managing director with LB Training and Development Ltd., course director for the M.Sc. in Clinical Research, School of Pharmacy at the University of Cardiff, and course director for M.Sc.
 
Deadline for Abstracts: 2019-03-31
 
Registration: https://www.compliance4all.com/control/w_product/~product_id=502387LIVE?channel=hum-molgen_Apr_2019_SEO
E-mail: compliance4all14@gmail.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.